The Department of Health and Human Services Food and Drug Administration awarded a definitive cost-no-fee contract to Duke University Office of Research Administration Division for the "Evaluating Fitness-for-Use of Electronic Health Records in Clinical Research" project. The contract has a potential value of $1,269,675.26 and a completion date of December 30, 2022. This contract is not set aside. As the prime contractor, Duke University will provide clinical research and...
The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
This federal contract award, valued at $699,087.00, was issued by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is a definitive Firm Fixed Price contract with a period of performance through March 12, 2028. It was awarded under a Broad Agency Announcement (BAA) that solicits research and development proposals to support the FDA's regulatory science and innovation agenda. Duke University, a leading academic research...
Duke University Office of Research Administration Division was awarded a $274,413 definitive contract by the Department of Health and Human Services Food and Drug Administration to conduct a study using electronic health records to identify and assess adverse events for biologic therapies. The contract aims to develop and validate methodological approaches under the agency's Broad Agency Announcement for the Advanced Research and Development of Regulatory Science, which seeks proposals to...
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
This federal contract was awarded to Duke University by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to support the development and deployment of COVID-19 vaccines under Operation Warp Speed. The $281,376.08 definitive cost-no-fee contract, awarded on September 17, 2021, does not have a set-aside designation. The contract supports research and development activities to advance regulatory science and innovation, which aligns with Duke University's expertise...
The U.S. government awarded Duke University, a private non-profit educational institution, a $2,359,896.00 cost-no-fee definitive contract for biomedical (applied/exploratory) research and development services. This contract does not have a set-aside designation. Duke University's Office of Research Administration Division is serving as the prime contractor. The contract was awarded on September 17, 2003 with a completion date of April 30, 2005. This award is not associated with a larger...
This is a $740,997 firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Duke University for research and development related to digital health technologies for infectious disease monitoring. The contract is not set aside under any small business program. Duke University is a prominent private research university with extensive experience managing federal contracts and grants across scientific and...
This federal contract award, valued at $400,734.35, was made by the Defense Health Agency to Duke University, a private non-profit university, for a new research contract. The award does not have a set-aside designation. The contract is a definitive contract of the cost-no-fee pricing type, with a performance period ending on December 29, 2018. Duke University's Office of Research Administration Division is the prime contractor. The award indicates that Duke University has been awarded...
This is a federal contract award to Duke University's Office of Research Administration Division, a private university, to provide biomedical research services. The contract has a potential value of $6,977,429.00 and was awarded on September 30, 2004 by an unspecified U.S. government agency. The contract is a definitive contract with a cost no fee pricing type and does not have any set-aside designations. Duke University has extensive experience delivering research services to various federal...